Table 1 Correlations between the mean platelet volume (MPV) and patients’ clinicopathological characteristics
From: Decreased mean platelet volume predicts poor prognosis in patients with pancreatic cancer
MPVHigh (n = 40) n (%) | MPVLow (n = 51) n (%) | P value | |
|---|---|---|---|
Age | |||
< 75 Years | 21 (52.5%) | 32 (62.7%) | 0.39 |
≥ 75 Years | 19 (47.5%) | 19 (37.3%) | |
Sex | |||
Male | 22 (55.5%) | 35 (68.6%) | 0.20 |
Female | 18 (44.5%) | 16 (31.4%) | |
Anti-platelet therapy | |||
Absent | 35 (87.5%) | 43 (84.3%) | 0.77 |
Present | 5 (12.5%) | 8 (15.7%) | |
Tumor size | |||
Small (< 3 cm) | 24 (60.0%) | 31 (60.8%) | 0.94 |
Large (≥ 3 cm) | 16 (40.0%) | 20 (39.2%) | |
Tumor location | |||
Head | 24 (60.0%) | 32 (62.7%) | 0.90 |
Body/Tail | 16 (40.0%) | 19 (37.3%) | |
Histologya | |||
wel | 23 (57.5%) | 24 (47.1%) | 0.40 |
Mod / por / muc/ anaplastic | 17 (42.5%) | 27 (52.9%) | |
T categoryb | |||
T1/T2 | 3 (7.5%) | 4 (7.8%) | 0.95 |
T3 | 37 (92.5%) | 47 (92.2%) | |
Lymph node metastasis | |||
Absent | 20 (50.0%) | 17 (33.3%) | 0.13 |
Present | 20 (50.0%) | 34 (66.7%) | |
Lymphatic invasionc | |||
ly 0/1 | 30 (75.0%) | 23 (45.1%) | 0.005 |
ly 2/3 | 10 (25.0%) | 28 (54.9%) | |
Vascular invasiond | |||
v 0/1 | 14 (35.0%) | 32 (62.7%) | 0.011 |
v 2/3 | 26 (65.0%) | 19 (37.3%) | |
Intrapancreatic nerve invasione | |||
ne 0/1 | 10 (25.0%) | 11 (21.6%) | 0.80 |
ne 2/3 | 30 (75.0%) | 40 (78.4%) | |
Surgical procedure | |||
PD | 24 (60.0%) | 34 (66.7%) | 0.52 |
DP/TP | 16 (40.0%) | 17 (33.3%) | |
Residual tumor | |||
R0 | 36 (90.0%) | 47 (92.2%) | 0.73 |
R1 | 4 (10.0%) | 4 (7.8%) | |
Neoadjuvant chemotherapy | |||
Absent | 35 (87.5%) | 43 (84.3%) | 0.77 |
Present | 5 (12.5%) | 8 (15.7%) | |
Adjuvant chemotherapy | |||
Absent | 18 (45.0%) | 21 (41.2%) | 0.83 |
Present | 22 (55.0%) | 30 (58.8%) |